| Date Filed | Type | Description |
| 06/09/2023 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
| 04/28/2023 |
4
| Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 10,900 shares
@ $26.34, valued at
$287.1k
Exercised 24,575 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 13,211 shares
@ $26.1, valued at
$344.8k
Exercised 30,060 restricted stock units
@ $0 |
|
| 03/10/2023 |
4
| Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,232 shares
@ $26.91, valued at
$113.9k
Granted 60,004 restricted stock units
@ $0
Granted 130,998 options to buy
@ $0
Exercised 14,419 restricted stock units
@ $0 |
|
| 06/24/2022 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 38,000 options to buy
@ $1.31, valued at
$49.8k
|
|
| 06/13/2022 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 12,155 options to buy
@ $3.1, valued at
$37.7k
|
|
| 03/15/2022 |
4
| Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 90,179 restricted stock units
@ $0
Granted 208,821 options to buy
@ $0 |
|
| 03/14/2022 |
4
| Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Bought 4,287 shares
@ $25.359, valued at
$108.7k
Bought 3,813 shares
@ $25.814, valued at
$98.4k
|
|
| 03/11/2022 |
4
| Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Exercised 14,420 restricted stock units
@ $0 |
|
| 03/03/2022 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 5,017 options to buy
@ $16.13, valued at
$80.9k
|
|
| 01/06/2022 |
3
| Blanchard Cheryl R (Director) has filed a Form 3 on Vigil Neuroscience, Inc. |
| 06/24/2021 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.46, valued at
$43.8k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2020 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Granted 30,000 shares
@ $0 |
|
| 04/28/2020 |
4
| Blanchard Cheryl R (President, CEO, Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Exercised 4,231 shares
@ $0
Paid exercise price by delivering 1,794 shares
@ $33.4, valued at
$59.9k
Granted 73,726 restricted stock units
@ $0
Granted 104,638 options to buy
@ $33.4, valued at
$3.5M
|
|
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/30/2019 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Granted 3,723 shares
@ $0
Granted 7,347 options to buy
@ $13.43, valued at
$98.7k
|
|
| 02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2019 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on Neuronetics, Inc.|
Txns:
| Granted 714 shares
@ $0
Granted 1,453 options to buy
@ $17.45, valued at
$25.4k
|
|
| 02/15/2019 |
3
| Blanchard Cheryl R (Director) has filed a Form 3 on Neuronetics, Inc. |
| 09/05/2018 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on Anika Therapeutics, Inc.|
Txns:
| Granted 3,624 shares
@ $0 |
|
| 09/05/2018 |
3
| Blanchard Cheryl R (Director) has filed a Form 3 on Anika Therapeutics, Inc. |
| 05/31/2018 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on SeaSpine Holdings Corp|
Txns:
| Granted 8,857 shares
@ $0 |
|
| 06/15/2017 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on SeaSpine Holdings Corp|
Txns:
| Granted 10,081 shares
@ $0 |
|
| 06/09/2016 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on SeaSpine Holdings Corp |
| 08/04/2015 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on SeaSpine Holdings Corp|
Txns:
| Granted 54,054 options to buy
@ $15.68, valued at
$847.6k
|
|
| 03/21/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/20/2012 |
4
| Blanchard Cheryl R (Sr. VP, Chief Scientific Off.) has filed a Form 4 on ZIMMER HOLDINGS INC|
Txns:
| Paid exercise price by delivering 1,348 shares
@ $63.94, valued at
$86.2k
Exercised 4,368 restricted stock units
@ $0 |
|
| 02/23/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|